Brooks Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Brooks Laboratories Limited generated cash of -$96,806,000, which is more than the previous year. Cash used in financing activities reached the amount of $96,007,000 last year. Net change in cash is therefore $1,023,000.
Cash Flow
| 2010 | 56.90M | -27.89M | -42.43M |
|---|---|---|---|
| 2011 | 39.59M | -8.41M | -31.04M |
| 2012 | -17.83M | -410.17M | 606.13M |
| 2016 | 81.18M | -135.61M | 43.19M |
| 2018 | -61.81M | -51.35M | 118.22M |
| 2020 | -93.88M | -23.25M | 96.12M |
| 2021 | 44.58M | -51.29M | 11.58M |
| 2023 | -144.90M | 4.94M | 114.14M |
| 2024 | -96.80M | 1.82M | 96.00M |
BROOKS.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 232K | 26.05M | 3.95M | 24.98M | 1.39M | 14.91M | 8.71M | 8.58M | 21.99M |
Operating activities | |||||||||
Net income | -195.91M | -354.25M | -89.93M | -135.13M | -175.34M | 106.90M | 88.35M | 68.88M | 51.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 17.73M | 70.26M | 71.43M | 66.47M | 64.45M | 11.6M | 6.56M | 6.11M | 5.18M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -33.83M | -26.87M | 19.94M | -44.77M | -6.65M | 3.80M | 0 | 0 | 0 |
Inventories | 16.92M | 32.86M | -98.28M | -37.21M | -37.10M | 8.44M | 3.41M | -7.75M | -12.54M |
Accounts payable | -78.89M | 108.37M | 47.37M | -10.73M | 81.31M | -31.19M | 0 | 0 | 0 |
Cash generated by operating activities | -96.80M | -144.90M | 44.58M | -93.88M | -61.81M | 81.18M | -17.83M | 39.59M | 56.90M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -184.95M | 0 | -3.12M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.39M | -4.67M | -56.13M | -25.83M | -57.32M | -359.08M | -229.68M | -9.24M | -27.89M |
Acquisitions Net | 0 | 176.29M | 0 | 4.3M | 780K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1.82M | 4.94M | -51.29M | -23.25M | -51.35M | -135.61M | -410.17M | -8.41M | -27.89M |
Financing activities | |||||||||
Common Stock Issued | 112.67M | 0 | 0 | 175.47M | 0 | 0 | 630M | 500K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -8.70M | -40.32M | -43.81M | -42.59M | 143.89M | 51.13M | -9.01M | -31.54M | -42.43M |
Cash used in financing activities | 96.00M | 114.14M | 11.58M | 96.12M | 118.22M | 43.19M | 606.13M | -31.04M | -42.43M |
Net Change In Cash | 1.02M | -25.81M | 4.88M | -21.02M | 5.05M | -11.24M | 178.12M | 129K | -13.41M |
Cash at end of period | 1.25M | 232K | 8.83M | 3.96M | 6.45M | 3.67M | 186.83M | 8.71M | 8.58M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |